The Uromigos

The Uromigos

Health EN ↓ 485 episodi

Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visita il sito del podcast e sostieni chi lo crea: www.uromigos.org

Autore

The Uromigos

Categoria

Health

Sito del podcast

www.uromigos.org

Ultimo episodio

5 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer 08.06.2021

Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor. 

Episode 110: PEACE1 - Triplet therapy in prostate cancer 08.06.2021

Karim Fizazi describes the results of this randomised, potentially practice-changing trial. 

Episode 109: Adjuvant pembrolizumab in renal cancer 07.06.2021

Toni Choueiri describes the KN564 study in detail.

Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer 07.06.2021

Tom and Peter continue to see things differently - has the data changed things? 

Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing 07.06.2021

Matt Galsky describes his Phase 2 study and gives a vision of the future.

Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021 07.06.2021

Andrea Necchi gives a summary of the three abstracts. 

Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer 07.06.2021

Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.

Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer 06.06.2021

Mike Morris does his stuff. 

Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer 06.06.2021

Monty Pal describes a small randomised trial of ipi/nivo plus CMB588.

Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community 28.05.2021

James Larkin describes learning from adjuvant immune checkpoint inhibitors in melanoma. 

Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer 26.05.2021

Eric Jonasch gives an overview of the recent Nature Medicine publication. 

Episode 100: The Uromigos 100th Podcast - Looking to the Future 21.05.2021

Chris Sweeney, Kala Sridhar and David McDermott discuss the future. 

Episode 99: Navigating social media from a patients' perspective 19.05.2021

Dena Battle is the co-founder and president of KCure and a passionate kidney cancer patient advocate. 

Episode 98: Bladder cancer from a patient perspective 19.05.2021

Dr. Lydia Makaroff, Vice President of the World Bladder Cancer Patient Coalition, discusses key issues for bladder cancer. 

Episode 97: Sacituzumab Govitecan in Bladder Cancer 04.05.2021

Petros Grivas discusses the recent accelerated approval and JCO paper data.

Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo 28.04.2021

Andrea Apolo discusses highlights from the April 28th meeting. 

Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia 28.04.2021

Jorge Garcia discusses the pembrolizumab and atezolizumab bladder cancer dangling accelerated approvals and the ODAC process

Episode 94: EIKCS Summary of Day 1 23.04.2021

Samra Turajlic summarised the meetings and looks forward to Day 2...

Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer 14.04.2021

Silke Gillessen discusses the back to back JCO papers on this topic. 

Episode 92: Second line therapy in advanced RCC 09.04.2021

Viktor Grünwald discusses treatment for progression of disease after front lines PD1 based therapy. 

Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer 26.03.2021

Joaquim Bellmunt describes this study as well as adjuvant nivolumab and ctDNA in bladder cancer. 

Episode 90: The Uromigos Podcast with QOL Expert David Cella 12.03.2021

Everything you wanted to know about quality of life assessment in cancer but were too afraid to ask. 

Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer 04.03.2021

David McDermott describes these back to back JCO publications. 

Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler 26.02.2021

In these podcasts, we explore academic career development with individuals in different stages of their career. 

Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal 26.02.2021

In these podcasts, we explore academic career development with individuals at different stages in their career. 

Ascolta il podcast The Uromigos su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici